The suppression of YAP/TAZ activity in in vivo studies of breast cancer, pancreatic cancer, and osteosarcoma have also demonstrated the contribution of these downstream Hippo proteins on tumorigenesis (51, 54, 55). The gene discussed is YAP1; the disease is osteosarcoma.